• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by DXC Technology Company (Amendment)

    2/14/24 4:47:04 PM ET
    $DXC
    EDP Services
    Technology
    Get the next $DXC alert in real time by email
    SC 13G/A 1 sayw24021424_13ga.htm


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549



    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    (Amendment No. 1)*

    DXC TECHNOLOGY COMPANY
    (Name of Issuer)

    Common Stock, $0.01 par value per share
    (Title of Class of Securities)

    23355L106
    (CUSIP Number)

    December 31, 2023
    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐
    Rule 13d-1(b)

    ☒
    Rule 13d-1(c)

    ☐
    Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    Continued on following pages
    Page 1 of 10 Pages
    Exhibit Index: Page 8



    CUSIP No. 23355L106
    Page 2 of 10 Pages
    1
    NAMES OF REPORTING PERSONS
     
     
    GLENVIEW CAPITAL MANAGEMENT, LLC
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    13,006,623
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    13,006,623
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    13,006,623
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    6.86%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    OO
     
     
     
     


    CUSIP No. 23355L106
    Page 3 of 10 Pages
    1
    NAMES OF REPORTING PERSONS
     
     
    LARRY ROBBINS
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    United States of America
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    150
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    13,006,623
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    150
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    13,006,623
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    13,006,773
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    6.86%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    IN, HC
     
     
     
     


    CUSIP No. 23355L106
    Page 4 of 10 Pages
    Item 1(a).
    Name of Issuer:

    DXC Technology Company (the “Issuer”)

    Item 1(b).
    Address of Issuer’s Principal Executive Offices:

    20408 Bashan Drive, Suite 231, Ashburn, Virginia 20147

    Item 2(a).
    Name of Person Filing:

    This Statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”):

    i) Glenview Capital Management, LLC (“Glenview Capital Management”); and
    ii) Larry Robbins (“Mr. Robbins”).

    This Statement relates to Shares (as defined herein) held for the accounts of Glenview Capital Partners, L.P., a Delaware limited partnership (“Glenview Capital Partners”), Glenview Capital Master Fund, Ltd., a Cayman Islands exempted company (“Glenview Capital Master Fund”), Glenview Capital Opportunity Fund, L.P., a Delaware limited partnership (“Glenview Capital Opportunity Fund”), Glenview Offshore Opportunity Master Fund, Ltd., a Cayman Islands exempted company (“Glenview Offshore Opportunity Master Fund”), and a custodial account controlled by Mr. Robbins.

    Glenview Capital Management serves as investment manager to each of Glenview Capital Partners, Glenview Capital Master Fund, Glenview Capital Opportunity Fund and Glenview Offshore Opportunity Master Fund. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management.

    Item 2(b).
    Address of Principal Business Office or, if None, Residence:

    The address of the principal business office of each of Glenview Capital Management and Mr. Robbins is 767 Fifth Avenue, 44th Floor, New York, New York 10153.

    Item 2(c).
    Citizenship:

    i) Glenview Capital Management is a Delaware limited liability company;
    ii) Mr. Robbins is a citizen of the United States of America.

    Item 2(d).
    Title of Class of Securities:

    Common Stock, $0.01 par value per share (the “Shares”)

    Item 2(e).
    CUSIP Number:

    23355L106

    Item 3.
    If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

    This Item 3 is not applicable.


    CUSIP No. 23355L106
    Page 5 of 10 Pages
    Item 4.
    Ownership:

    Item 4(a).
    Amount Beneficially Owned:

    As of December 31, 2023, Glenview Capital Management may be deemed the beneficial owner of 13,006,623 Shares. This amount consists of: (A) 288,715 Shares held for the account of Glenview Capital Partners; (B) 3,206,028 Shares held for the account of Glenview Capital Master Fund; (C) 7,642,344 Shares held for the account of Glenview Capital Opportunity Fund; and (D) 1,869,536 Shares held for the account of Glenview Offshore Opportunity Master Fund.

    As of December 31, 2023, Mr. Robbins may be deemed the beneficial owner of 13,006,773 Shares. This amount consists of the 13,006,623 Shares beneficially owned by Glenview Capital Management plus 150 Shares held in a custodial account controlled by Mr. Robbins.

    Item 4(b).
    Percent of Class:

    As of December 31, 2023, each of the Reporting Persons may be deemed the beneficial owner of approximately 6.86% of Shares outstanding. (There were 189,468,954 Shares outstanding as of December 31, 2023, based on the Issuer’s quarterly report on Form 10-Q filed on February 2, 2024.)

    Item 4(c).
    Number of Shares as to Which Such Person has:

    Glenview Capital Management:
    (i) Sole power to vote or direct the vote:
    0
    (ii) Shared power to vote or direct the vote:
    13,006,623
    (iii) Sole power to dispose or direct the disposition of:
    0
    (iv) Shared power to dispose or direct the disposition of:
    13,006,623

    Mr. Robbins:
    (i) Sole power to vote or direct the vote:
    150
    (ii) Shared power to vote or direct the vote:
    13,006,623
    (iii) Sole power to dispose or direct the disposition of:
    150
    (iv) Shared power to dispose or direct the disposition of:
    13,006,623

    Item 5.
    Ownership of Five Percent or Less of a Class:

    This Item 5 is not applicable.

    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person:

    See disclosure in Items 2 and 4 hereof. Certain funds and the custodial account listed in Item 2(a) are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares covered by this Statement that may be deemed to be beneficially owned by the Reporting Persons.

    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:

    See disclosure in Item 2 hereof.

    Item 8.
    Identification and Classification of Members of the Group:

    This Item 8 is not applicable.

    Item 9.
    Notice of Dissolution of Group:

    This Item 9 is not applicable.


    CUSIP No. 23355L106
    Page 6 of 10 Pages
    Item 10.
    Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.


    CUSIP No. 23355L106
    Page 7 of 10 Pages
    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


    GLENVIEW CAPITAL MANAGEMENT, LLC




    By:
    /s/ Mark J. Horowitz

     
    Mark J. Horowitz


    Co-President of Glenview Capital Management, LLC




    LARRY ROBBINS




    By:
    /s/ Mark J. Horowitz


    Mark J. Horowitz, attorney-in-fact for Larry Robbins



    February 14, 2024




    CUSIP No. 23355L106
    Page 8 of 10 Pages
    EXHIBIT INDEX
    Ex.
    Page No.
    A
    Joint Filing Agreement
    9
    B
    Power of Attorney
    10


    CUSIP No. 23355L106
    Page 9 of 10 Pages
    EXHIBIT A

    JOINT FILING AGREEMENT

    The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of DXC Technology Company dated as of February 14, 2024 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.


    GLENVIEW CAPITAL MANAGEMENT, LLC




    By:
    /s/ Mark J. Horowitz


    Mark J. Horowitz


    Co-President of Glenview Capital Management, LLC




    LARRY ROBBINS




    By:
    /s/ Mark J. Horowitz


    Mark J. Horowitz, attorney-in-fact for Larry Robbins



    February 14, 2024




    CUSIP No. 23355L106
    Page 10 of 10 Pages
    EXHIBIT B

    POWER OF ATTORNEY

    KNOW ALL MEN BY THESE PRESENT, that I, Larry Robbins, hereby make, constitute and appoint Mark J. Horowitz, acting individually, as my agent and attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as Chief Executive Officer or in other capacities of Glenview Capital Management, LLC, a Delaware limited liability company, and each of its affiliates or entities advised or controlled by me or Glenview Capital Management, LLC, all documents, certificates, instruments, statements, filings and agreements (“documents”) to be filed with or delivered to any foreign or domestic governmental or regulatory body or required or requested by any other person or entity pursuant to any legal or regulatory requirement relating to the acquisition, ownership, management or disposition of securities, futures contracts or other investments, and any other documents relating or ancillary thereto, including, without limitation, all documents relating to filings with the United States Securities and Exchange Commission (the “SEC”) pursuant to the Securities Act of 1933, as amended, or the Securities and Exchange Act of 1934, as amended (the “Act”), and the rules and regulations promulgated thereunder, including, without limitation: (1) all documents relating to the beneficial ownership of securities required to be filed with the SEC pursuant to Section 13(d) or Section 16(a) of the Act, including, without limitation: (a) any acquisition statements on Schedule 13D or Schedule 13G and any amendments thereto, (b) any joint filing agreements pursuant to Rule 13d-1(k), and (c) any initial statements of, or statements of changes in, beneficial ownership of securities on Form 3, Form 4 or Form 5 and (2) any information statements on Form 13F required to be filed with the SEC pursuant to Section 13(f) of the Act.

    All past acts of the attorney-in-fact in furtherance of the foregoing are hereby ratified and confirmed.

    This Power of Attorney revokes the previous Power of Attorney, executed by the undersigned on February 10, 2009, and shall remain in effect until revoked, in writing, by the undersigned.

    IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney, this 2nd day of February, 2016.

    /s/ Larry Robbins

    Larry Robbins


    Get the next $DXC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DXC

    DatePrice TargetRatingAnalyst
    3/19/2024$22.00Neutral
    Guggenheim
    1/24/2024$27.00 → $24.00Neutral → Underweight
    JP Morgan
    1/17/2024$24.00 → $21.00Neutral → Sell
    Citigroup
    10/17/2023$22.00Peer Perform → Underperform
    Wolfe Research
    8/3/2023$34.00 → $25.00Outperform → Market Perform
    TD Cowen
    8/3/2023$32.00 → $25.00Buy → Neutral
    Citigroup
    8/3/2023$35.00 → $23.00Buy → Hold
    Deutsche Bank
    8/3/2023$34.00 → $29.00Outperform → Sector Perform
    RBC Capital Mkts
    More analyst ratings